Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2022-02-16 Regulatory Filings
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA launches SmectaGO[®] - an innovative on-the-go product for treatment of diarrhea
Regulatory Filings Classification · 95% confidence The document is a short press release dated February 16, 2022, announcing the launch of a new product, SmectaGO®, in Nordic pharmacies through an agreement with Ipsen. It details the product, market strategy, and includes contact information. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a formal regulatory filing like a proxy statement (DEF 14A). Since it announces a specific business development (product launch/distribution agreement) that doesn't fit the other specific categories (like M&A, Capital Change, or Director Dealing), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard corporate announcements, or potentially a general announcement category if one existed. Given the provided definitions, RNS is the most appropriate general announcement category for this type of news release that isn't a financial report or management change.
2022-02-16 English
Navamedic ASA: Invitation to 2021 Fourth quarter presentation
Report Publication Announcement Classification · 96% confidence The document is a short invitation to a presentation of the 2021 fourth-quarter results, specifying the date, time, location, and participants. It is not the full financial report (IR or 10-K) nor the transcript of the call (CT). Since it is an announcement about an upcoming event where results will be presented, and it doesn't fit the specific categories like DIV, DIRS, or MANG, it is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if the invitation implies the presentation material itself is the focus. Given the brevity and the nature of inviting people to hear the results, RNS is the most appropriate fallback for an announcement of an event, although IP is also plausible if the presentation slides are the main deliverable being announced. Given the context of financial reporting, RNS serves as the general announcement category when a more specific one like ER (which usually contains the highlights) is not appropriate for an invitation.
2022-02-14 English
Navamedic ASA: Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Navamedic ASA: Trading Update' and provides preliminary, updated revenue growth expectations for the full year 2021 (around 30% vs. 20% target). It explicitly states that the final numbers will be communicated on February 17, 2022, when the Q4 numbers are presented. This document is an announcement providing key financial highlights ahead of the official report, making it an Earnings Release (ER). It is not the full report (IR or 10-K) nor is it a general announcement about publishing a report (RPA). FY 2021
2021-12-23 English
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is titled 'Financial calendar' and lists scheduled dates for various corporate events, specifically mentioning the 'Annual Report', 'Quarterly Report', and 'Annual General Meeting' release dates for 2021 and 2022. It does not contain the content of any of these reports, but rather announces *when* they will be published. This fits the definition of announcing the publication of reports, making 'Report Publication Announcement' (RPA) the most appropriate classification, as it signals future or scheduled releases. If the document were the actual Annual Report, it would be classified as 10-K. If it were the actual AGM materials, it would be AGM-R. Since it is only a schedule/calendar of these events, RPA is the best fit.
2021-12-06 English
Navamedic ASA has entered into a market making agreement with Norne Securities AS
Regulatory Filings Classification · 99% confidence The document is a short announcement from Navamedic ASA dated November 11, 2021, stating that it has entered into a market making agreement with Norne Securities AS to enhance liquidity. This type of announcement, which details a specific corporate action related to trading or market structure but does not fit neatly into standard financial reporting (like 10-K, ER, or IR), is best classified as a general regulatory announcement or miscellaneous filing. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for such specific, non-standard corporate news that is not covered by other codes like DIRS, DIV, or CAP. The document length is short (1362 chars), but it is the primary content, not an announcement *of* another report, so RPA is not the best fit.
2021-11-11 English
Navamedic ASA: Resultater for tredje kvartal 2021
Interim / Quarterly Report Classification · 100% confidence The document is a detailed presentation titled 'Q3 2021 Third quarter results 2021 Navamedic ASA'. It contains comprehensive financial statements (P&L, Balance Sheet, Cash Flow), management commentary, and operational highlights for the third quarter of 2021. It is not a short announcement (it is over 25,000 characters) and provides substantive financial data, which qualifies it as an Interim/Quarterly Report (IR) rather than an Earnings Release (ER) or a Report Publication Announcement (RPA). Q3 2021
2021-11-04 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.